Zheng-Quan Yu
Overview
Explore the profile of Zheng-Quan Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie S, Ding J, Wang Z, Shi H, Yu Z
Front Genet
. 2025 Feb;
16:1518573.
PMID: 39944595
Background: Glioma, a primary intracranial tumor, is marked by high rates of mortality and disability, making it a significant health concern. Understanding the molecular mechanisms underlying glioma initiation and progression...
2.
Zhang H, Meng S, Chu K, Chu S, Fan Y, Bai J, et al.
J Cancer
. 2023 Jan;
13(15):3640-3651.
PMID: 36606197
Glioma is one of the most prevalent cancers diseases in the worldwide. Kinesin superfamily protein 4 (KIF4), a KIF member classified in Kinesin 4 has been indicated as a mediator...
3.
Lu J, Wang Y, Zhang Y, Shen M, Li H, Yu Z, et al.
Neural Regen Res
. 2021 Mar;
16(10):1950-1957.
PMID: 33642365
The regulation of mRNA localization and local translation play vital roles in the maintenance of cellular structure and function. Many human neurodegenerative diseases, such as fragile X syndrome, amyotrophic lateral...
4.
Dai J, Cai J, Sun J, Lin Q, Yu Z
Clin Chim Acta
. 2020 Aug;
510:354-359.
PMID: 32738268
Background: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) might contribute to brain inflammation after acute brain injury. The current study was designed to investigate whether serum soluble TWEAK (sTWEAK)...
5.
Chen X, Mao Y, Yu Z, Wu J, Chen G
Med Gas Res
. 2020 Mar;
10(1):50-53.
PMID: 32189670
Glioma is one of the most frequent primary brain tumors. Currently, the most common therapeutic strategy for patients with glioma is surgical resection combined with radiotherapy or/and adjuvant chemotherapy. However,...
6.
Liu Y, Chen M, Cheng L, Zhang Z, Yu Z, Jiang Q, et al.
Oncogene
. 2018 Mar;
37(21):2890-2902.
PMID: 29520106
We previously identified a pivotal role for G protein α inhibitory subunit 1 (Gαi1) in mediating PI3K-Akt signaling by receptor tyrosine kinases (RTKs). Here, we examined the expression and biological...
7.
Jiang M, Sun L, Feng D, Yu Z, Gao R, Sun Y, et al.
Med Gas Res
. 2017 May;
7(1):48-55.
PMID: 28480032
Isoflurane, a volatile and inhalational anesthetic, has been extensively used in perioperative period for several decades. A large amount of experimental studies have indicated that isoflurane exhibits neuroprotective properties when...
8.
Zhai W, Sun L, Yu Z, Chen G
Med Gas Res
. 2016 Nov;
6(2):111-118.
PMID: 27867477
Stroke, which is defined as a neurologic deficit caused by sudden impaired blood supply, has been considered as a common cause of death and disability for decades. The World Health...
9.
Zhang B, Ni H, Liu J, Lei Y, Li H, Xiong Y, et al.
Biochim Biophys Acta
. 2014 Sep;
1839(11):1161-9.
PMID: 25201174
Abnormally high transcription of the glial cell-line derived neurotrophic factor (gdnf) gene in glioma cells is related to the hyperacetylation of histone H3 lysine 9 (H3K9) in its promoter region...
10.
Yu Z, Zhang B, Ni H, Liu Z, Wang J, Ren Q, et al.
Mol Neurobiol
. 2014 Mar;
50(3):914-22.
PMID: 24619502
The mechanism underlying abnormally high transcription of the glial cell line-derived neurotrophic factor (GDNF) gene in glioma cells is not clear. In this study, to assess histone H3K9 acetylation levels...